The Net Margin of Sichuan Goldstone Asia Pharmaceutical Inc (300434.SZ) is 12.68%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2025-12-31 | 12.68% |
| 2024-12-31 | 8.32% |
| 2023-12-31 | 10.44% |
| 2022-12-31 | 17.61% |
| 2021-12-31 | 6.31% |
| 2020-12-31 | -88.47% |
| 2019-12-31 | 11.96% |
| 2018-12-31 | 15.37% |
| 2017-12-31 | 16.49% |
| 2016-12-31 | 15.70% |